Clinical trial
Treatment of Spastic Equinovarus Foot After Stroke. Efficacy: Association Between Ankle Foot Orthosis and Botulinum Toxin A (BTA) Injection
NCT00199589 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Treatment of Spastic Equinovarus Foot After Stroke. Efficacy: Association Between Ankle Foot Orthosis and Botulinum Toxin A (BTA) Injection
- Lead sponsor
- University Hospital, Limoges
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- October 31, 2002
- Completion date
- December 31, 2007
- Enrollment
- 46 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
spastic equinovarus